NCT00638937 2018-08-29AZD0530 to Treat Recurrent Stage IIIB/IV NSCLC Previously Treated With Combination ChemotherapyNational Cancer Institute (NCI)Phase 2 Completed37 enrolled 13 charts
NCT01000896 2010-02-04Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and PaclitaxelAstraZenecaPhase 1 Withdrawn27 enrolled